Browse Category

Mergers and Acquisitions 13 December 2025 - 22 December 2025

ABIVAX (ABVX) Stock Surges on Eli Lilly Takeover Talk as Nasdaq Biotech Index Inclusion Kicks In — News, Forecasts and Outlook (Dec. 22, 2025)

ABIVAX (ABVX) Stock Surges on Eli Lilly Takeover Talk as Nasdaq Biotech Index Inclusion Kicks In — News, Forecasts and Outlook (Dec. 22, 2025)

Abivax shares jumped about 10% to $126 in early U.S. premarket trading after reports of renewed takeover speculation involving Eli Lilly and confirmation of Abivax’s addition to the Nasdaq Biotechnology Index. French media said Lilly representatives met with France’s Treasury about a possible acquisition, though Reuters could not confirm the meeting. Both companies declined to comment on the rumors.
Amicus Therapeutics (FOLD) Stock Week Ahead: $14.50 BioMarin Buyout Puts the Deal Spread—and New Filings—Front and Center (Dec. 22–26, 2025)

Amicus Therapeutics (FOLD) Stock Week Ahead: $14.50 BioMarin Buyout Puts the Deal Spread—and New Filings—Front and Center (Dec. 22–26, 2025)

BioMarin Pharmaceutical agreed Friday to acquire Amicus Therapeutics for $14.50 per share in cash, valuing the company at $4.8 billion. FOLD shares closed near $14.18 after jumping 30% on the news. The deal is expected to close in Q2 2026, pending shareholder and regulatory approvals. Amicus disclosed a $175 million breakup fee and a June 19, 2026 outside date.
ServiceNow (NOW) Stock Week Ahead: Armis Deal Chatter, Moveworks Integration, 5-for-1 Split Fallout, and Fresh Analyst Targets

ServiceNow (NOW) Stock Week Ahead: Armis Deal Chatter, Moveworks Integration, 5-for-1 Split Fallout, and Fresh Analyst Targets

ServiceNow shares traded near $155 (split-adjusted) as of December 21, 2025, after a volatile week driven by reports of advanced talks to acquire Armis for up to $7 billion. The stock fell sharply on December 15 amid concerns over the deal’s size and a key analyst downgrade. ServiceNow recently completed a 5-for-1 stock split and closed its largest acquisition to date, Moveworks. No formal confirmation of the Armis deal has been issued.
Amicus Therapeutics (FOLD) Stock Today: BioMarin’s $14.50 Cash Buyout, Latest News, Analyst Forecasts, and What Comes Next (Dec. 21, 2025)

Amicus Therapeutics (FOLD) Stock Today: BioMarin’s $14.50 Cash Buyout, Latest News, Analyst Forecasts, and What Comes Next (Dec. 21, 2025)

BioMarin Pharmaceutical agreed to acquire Amicus Therapeutics for $14.50 per share in cash, valuing Amicus at $4.8 billion. Amicus closed at $14.20 on Dec. 19, just below the buyout price. The deal, approved by both boards, is expected to close in Q2 2026 pending regulatory and shareholder approval. BioMarin plans to fund the purchase with cash and about $3.7 billion in new debt.
Amicus Therapeutics (FOLD) Stock Jumps on BioMarin’s $4.8B Buyout: Latest News, Forecasts, and Deal Analysis as of Dec. 20, 2025

Amicus Therapeutics (FOLD) Stock Jumps on BioMarin’s $4.8B Buyout: Latest News, Forecasts, and Deal Analysis as of Dec. 20, 2025

BioMarin Pharmaceutical will acquire Amicus Therapeutics in an all-cash deal valued at $4.8 billion, offering $14.50 per share. Amicus stock surged about 30% after the Dec. 19 announcement, trading near $14.18 as of Dec. 20. The deal awaits regulatory and shareholder approval, with closing expected in Q2 2026. Trading volume spiked as investors focused on merger risk and timing.
Warner Bros. Discovery Stock (WBD) Forecast: Netflix Merger vs. Paramount’s $30 Bid Puts Shares in Deal-Driven Limbo (Dec. 20, 2025)

Warner Bros. Discovery Stock (WBD) Forecast: Netflix Merger vs. Paramount’s $30 Bid Puts Shares in Deal-Driven Limbo (Dec. 20, 2025)

Warner Bros. Discovery’s board urged shareholders to reject Paramount Skydance’s $30-per-share all-cash tender offer, citing financing concerns and a potential $4.3 billion cost if the Netflix deal is abandoned. WBD stock closed at $27.77 on Dec. 19, near Netflix’s $27.75 per-share offer. Netflix reaffirmed its commitment to its $72 billion deal. Paramount continues to push its cash bid.
Communication Services Stocks News Today (Dec. 20, 2025): Meta, Alphabet, Netflix–Warner Deal Shockwaves, and Telecom M&A Set Up 2026

Communication Services Stocks News Today (Dec. 20, 2025): Meta, Alphabet, Netflix–Warner Deal Shockwaves, and Telecom M&A Set Up 2026

Meta’s board lost Dina Powell McCormick after eight months, with no replacement planned, Reuters reported Dec. 19. Facebook is testing link-sharing limits for non-paying users, according to the Guardian. The XLC ETF’s top holdings remain Meta and Alphabet, with Warner Bros. Discovery now among the largest entertainment weights. Recent XLC net asset value sits near $116.
Qualcomm (QCOM) Stock News Today: Alphawave Semi Acquisition Closes, Analyst Targets Update, and 2026 AI Data-Center Outlook (Dec. 19, 2025)

Qualcomm (QCOM) Stock News Today: Alphawave Semi Acquisition Closes, Analyst Targets Update, and 2026 AI Data-Center Outlook (Dec. 19, 2025)

Qualcomm closed its $2.4 billion acquisition of Alphawave Semi on December 19, ahead of schedule, and named Alphawave CEO Tony Pialis to lead its data center business. Alphawave shares were delisted from the London Stock Exchange Friday morning. Qualcomm stock rose 1.37% to $176.58 as investors weighed the deal’s impact and debated the company’s valuation.
Howard Hughes Holdings (HHH) Stock Falls on Dec. 19, 2025 After $2.1B Vantage Deal: Latest News, Analyst Forecasts, and Key Risks

Howard Hughes Holdings (HHH) Stock Falls on Dec. 19, 2025 After $2.1B Vantage Deal: Latest News, Analyst Forecasts, and Key Risks

Howard Hughes Holdings shares fell about 5% to $79–$80 on Friday after announcing a $2.1 billion deal to acquire Vantage Group Holdings. The company will finance the purchase with cash and up to $1 billion in preferred stock issued to Pershing Square. The deal is expected to close in Q2 2026, pending regulatory approvals. Investors reacted to the company’s shift toward a diversified holding model.
TWO-PA Stock News Today (Dec. 17, 2025): UWM’s $1.3B Two Harbors Deal Puts Series A Preferred in Focus — What Holders Need to Know

TWO-PA Stock News Today (Dec. 17, 2025): UWM’s $1.3B Two Harbors Deal Puts Series A Preferred in Focus — What Holders Need to Know

UWM Holdings will acquire Two Harbors Investment Corp. in an all-stock deal valued at $1.3 billion, the companies announced December 17. Each Two Harbors Series A preferred share (TWO-PA) will be exchanged one-for-one into a newly issued UWM Series A preferred share at closing, expected in Q2 2026 pending approvals. Common shareholders will receive 2.3328 UWMC shares per TWO share.
ABIVAX Société Anonyme (ABVX) Stock News on Dec. 16, 2025: Shares Slide After Q3 Loss Widens, While Analysts Keep Buy Calls and M&A Talk Lingers

ABIVAX Société Anonyme (ABVX) Stock News on Dec. 16, 2025: Shares Slide After Q3 Loss Widens, While Analysts Keep Buy Calls and M&A Talk Lingers

Abivax shares fell about 5% in U.S. and Paris trading after reporting a nine-month net loss of €254.1 million, up from €136.9 million a year earlier. Cash and cash equivalents stood at €589.7 million as of September 30, expected to fund operations into Q4 2027. Investors weighed widening losses against a strong cash position and ongoing takeover speculation.
Coca-Cola Stock (NYSE: KO) News Today: Costa Coffee Sale Talks, CEO Succession, Dividend, and Analyst Price Targets (Dec. 15, 2025)

Coca-Cola Stock (NYSE: KO) News Today: Costa Coffee Sale Talks, CEO Succession, Dividend, and Analyst Price Targets (Dec. 15, 2025)

Coca-Cola shares traded near $70.72 on Dec. 15, 2025, up 0.28% in a narrow range. Reuters reports last-ditch talks with TDR Capital over a potential Costa Coffee sale, with price disagreements threatening the deal. The company is also managing a CEO transition and a dividend payout. Wall Street maintains a modestly positive outlook for KO.
ServiceNow (NOW) Stock Slides on Armis Deal Rumors, KeyBanc Downgrade, and a Looming 5-for-1 Split

ServiceNow (NOW) Stock Slides on Armis Deal Rumors, KeyBanc Downgrade, and a Looming 5-for-1 Split

ServiceNow shares fell about 11% to $767 Monday after reports the company is in advanced talks to acquire cybersecurity startup Armis for up to $7 billion. The drop followed a KeyBanc analyst downgrade citing AI disruption risks. The selloff comes days before ServiceNow’s planned 5-for-1 stock split. ServiceNow declined to comment on the reported deal.
Aegon Ltd Stock (AEG) Today: Transamerica Rebrand, U.S. Relocation Plan, Buybacks, and the UK Sale Watchlist (Dec. 15, 2025)

Aegon Ltd Stock (AEG) Today: Transamerica Rebrand, U.S. Relocation Plan, Buybacks, and the UK Sale Watchlist (Dec. 15, 2025)

Aegon Ltd shares traded near $7.63 midday Monday in New York as the company pursues a major shift to move its headquarters and legal seat to the U.S. and rebrand as Transamerica Inc. by 2028. The stock fell 8% in Amsterdam after the plan was announced, with investors weighing new financial targets, a buyback schedule, and a strategic review of the UK business.
ZIM Stock (NYSE: ZIM) in Focus: Takeover Bids, Proxy Fight, Dividend Signals, and Analyst Forecasts (Dec. 15, 2025)

ZIM Stock (NYSE: ZIM) in Focus: Takeover Bids, Proxy Fight, Dividend Signals, and Analyst Forecasts (Dec. 15, 2025)

ZIM Integrated Shipping shares fell 5.4% to $18.76 on Dec. 15, 2025, amid takeover speculation and a pending shareholder vote. The board confirmed a strategic review after receiving a non-binding acquisition proposal from CEO Eli Glickman and Rami Ungar. Reports say MSC and Hapag-Lloyd have also submitted bids. Any sale would require shareholder and Israeli government approval.
Compass Group PLC Stock (CPG.L) News, Forecasts and Analysis on 15 December 2025: Vermaat Deal Cleared as Analysts Target a Rebound

Compass Group PLC Stock (CPG.L) News, Forecasts and Analysis on 15 December 2025: Vermaat Deal Cleared as Analysts Target a Rebound

Compass Group shares hovered near 2,322p on Monday, close to the lower end of their 52-week range after the EU cleared its €1.5bn Vermaat acquisition. The stock is down 12.6% over 12 months. FY25 results showed $46.1bn revenue, $3,335m operating profit, and 8.7% organic growth. Several brokers say the pullback has improved the stock’s entry point.
Warner Bros. Discovery Stock (WBD) News Today: Netflix Deal vs. Paramount’s $30 Tender Offer, Antitrust Pushback, and What Comes Next (Dec. 14, 2025)

Warner Bros. Discovery Stock (WBD) News Today: Netflix Deal vs. Paramount’s $30 Tender Offer, Antitrust Pushback, and What Comes Next (Dec. 14, 2025)

Warner Bros. Discovery closed Friday at $29.98 with 45.7 million shares traded, as takeover speculation intensified. Netflix has signed a deal to buy WBD’s studios and streaming business after a spin-off, while Paramount Skydance has launched a hostile all-cash bid for the entire company. Senator Tim Scott urged regulators to scrutinize the Netflix deal. WBD plans to respond to Paramount’s offer within 10 business days.
ServiceNow (NOW) Stock News Today: Armis Acquisition Talks, 5-for-1 Stock Split Countdown, and Fresh Analyst Forecasts (Dec. 14, 2025)

ServiceNow (NOW) Stock News Today: Armis Acquisition Talks, 5-for-1 Stock Split Countdown, and Fresh Analyst Forecasts (Dec. 14, 2025)

ServiceNow is in advanced talks to acquire cybersecurity firm Armis in a deal valued up to $7 billion, according to multiple reports. The news comes days before ServiceNow’s planned 5-for-1 stock split. Shares last traded near $865 before U.S. markets closed for the weekend. Both companies declined to comment.
Macquarie Group Ltd (ASX: MQG) Stock Update (14 Dec 2025): Dividend Week, Buyback Support, Qube Deal Watch, and Analyst Forecasts for the Week Ahead

Macquarie Group Ltd (ASX: MQG) Stock Update (14 Dec 2025): Dividend Week, Buyback Support, Qube Deal Watch, and Analyst Forecasts for the Week Ahead

Macquarie Group shares closed Friday at A$201.57, up 2.66% for the day and 2.95% for the week. The interim dividend of A$2.80 per share is due Wednesday, with DRP shares priced at A$195.34. Macquarie has extended its up to A$2 billion on-market buyback for another year. Investors are also watching regulatory moves and the Qube takeover bid.
Constellation Energy (CEG) Stock This Week: Calpine Deal Nears Closing, Nuclear “Data Economy” Tailwinds, and What Investors Watch Next Week (Updated Dec. 12, 2025)

Constellation Energy (CEG) Stock This Week: Calpine Deal Nears Closing, Nuclear “Data Economy” Tailwinds, and What Investors Watch Next Week (Updated Dec. 12, 2025)

Constellation Energy shares fell 7.03% Friday, closing at $351.98 after an early surge to $380.78 reversed sharply. The drop erased gains from earlier in the week, leaving the stock down 1.6% from Monday’s close. The moves follow news that Constellation cleared its final regulatory hurdle for the $16.4 billion Calpine acquisition, including DOJ and FERC-mandated divestitures. Trading volume Friday reached 3.78 million shares.
Go toTop